MedPath

Akela Pharma, Inc.

Akela Pharma, Inc. logo
🇺🇸United States
Ownership
Private
Established
1996-01-01
Employees
1
Market Cap
-
Website
http://akelapharma.com

Safety of Fentanyl TAIFUN Treatment

Phase 3
Conditions
Breakthrough Cancer Pain
Interventions
First Posted Date
2009-01-14
Last Posted Date
2009-01-14
Lead Sponsor
Akela Pharma, Inc.
Target Recruit Count
500
Registration Number
NCT00822614
Locations
🇵🇱

NZOZ, Wloclawek, Wolnosc, Poland

© Copyright 2025. All Rights Reserved by MedPath